[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2019

December 2019 | 114 pages | ID: TFAB96AAABB0EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2019' provides an overview of Transcatheter Mitral Valve Implantation (TMVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Mitral Valve Implantation (TMVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Transcatheter Mitral Valve Implantation (TMVI) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
3.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
3.3 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
3.4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
3.5 Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials

4 TRANSCATHETER MITRAL VALVE IMPLANTATION (TMVI) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development

5 TRANSCATHETER MITRAL VALVE IMPLANTATION (TMVI) COMPANIES AND PRODUCT OVERVIEW

5.1 4C Medical Technologies Inc Company Overview
  5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Annulon Company Overview
  5.2.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview
5.3 CardioMech AS Company Overview
  5.3.1 CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardiovalve Ltd Company Overview
  5.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cephea Valve Technologies, Inc. Company Overview
  5.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Colibri Heart Valve LLC Company Overview
  5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Daidalos Solutions BV Company Overview
  5.7.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.8 Direct Flow Medical Inc (Inactive) Company Overview
  5.8.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 Dura LLC Company Overview
  5.9.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Edwards Lifesciences Corp Company Overview
  5.10.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Emory University Company Overview
  5.11.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Foldax Inc Company Overview
  5.12.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 HighLife SAS Company Overview
  5.13.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
5.14 LivaNova PLC Company Overview
  5.14.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Medtronic plc Company Overview
  5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Micro Interventional Devices, Inc. Company Overview
  5.16.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 MitrAssist Ltd. Company Overview
  5.17.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.18 MValve Technologies Ltd. Company Overview
  5.18.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.19 NaviGate Cardiac Structures, Inc. Company Overview
  5.19.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.20 Neovasc Inc Company Overview
  5.20.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Polares Medical SA Company Overview
  5.21.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.22 Sino Medical Sciences Technology Inc Company Overview
  5.22.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Trinity College Dublin Company Overview
  5.23.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.24 University College London Company Overview
  5.24.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.25 Venus MedTech Company Overview
  5.25.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview

6 TRANSCATHETER MITRAL VALVE IMPLANTATION (TMVI)- RECENT DEVELOPMENTS

6.1 Nov 21, 2019: LivaNova to revamp heart valve division to affect 150 jobs
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.3 Oct 23, 2019: Edwards Lifesciences reports third quarter results
6.4 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes
6.5 Oct 15, 2019: Neovasc announces Notice of US Patent Granted for TiaraTranscatheter Device for treatment of severe mitral regurgitation
6.6 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica
6.7 Sep 30, 2019: AltaValve, 4C Medical's Novel Transcatheter Mitral Regurgitation Device Highlighted at TCT 2019
6.8 Sep 27, 2019: Medtronic announces early feasibility Trial for Intrepid Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal approach
6.9 Aug 28, 2019: Medtronic announces planned leadership succession
6.10 Aug 20, 2019: Medtronic reports first quarter financial results for 2019
6.11 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
6.12 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
6.13 Jun 17, 2019: Tiara featured in presentation at 11th Annual TVT 2019 English
6.14 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
6.15 May 22, 2019: Edwards announces milestones for Transcatheter Mitral Program
6.16 May 20, 2019: Novel technique reduces obstruction risk in heart valve replacement
6.17 Apr 23, 2019: Edwards Lifesciences announces first quarter results
6.18 Apr 17, 2019: Neovasc announces resolution of last remaining active litigation
6.19 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai
6.20 Mar 21, 2019: Neovasc wins German court appeal; announces german court's Decision to dismiss CardiAQ's claim to co-inventorship of a European patent for Tiara
6.21 Mar 04, 2019: Neovasc's Tiara Mitral Valve replacement technology featured in update presentation at the CRT 2019 Meeting
6.22 Feb 25, 2019: 4C Medical's novel mitral regurgitation therapy to be highlighted at CRT 2019 Meeting
6.23 Feb 21, 2019: Edwards Lifesciences secures CE-Mark for Pascal system
6.24 Feb 21, 2019: Neovasc celebrates 5-year anniversary of Tiara patient as the longest surviving transcatheter mitral valve replacement in the world
6.25 Feb 20, 2019: Micro Interventional Devices reaches settlement agreement with Neovasc
6.26 Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018
6.27 Jan 29, 2019: Neovasc receives approval to proceed with phase 2 of TIARA-II study from clinical regulators in Germany and the UK
6.28 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
6.29 Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement
6.30 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
Table 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
Table 6: Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AltaValve - Product Status
Table 10: AltaValve - Product Description
Table 11: 4C Medical Technologies Inc - Ongoing Clinical Trials Overview
Table 12: AltaValve - AltaValve Early Feasibility Study Protocol
Table 13: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Mitral Valve Replacement Device - Product Status
Table 15: Mitral Valve Replacement Device - Product Description
Table 16: CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Transcatheter Mitral Valve Repair System - Product Status
Table 18: Transcatheter Mitral Valve Repair System - Product Description
Table 19: Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Valtech Cardiovalve - Product Status
Table 21: Valtech Cardiovalve - Product Description
Table 22: Cardiovalve Ltd - Ongoing Clinical Trials Overview
Table 23: Valtech Cardiovalve - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation
Table 24: Valtech Cardiovalve - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
Table 25: Valtech Cardiovalve - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Table 26: Valtech Cardiovalve - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System (AHEAD Study)
Table 27: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Mitral Valve Replacement Device - Product Status
Table 29: Mitral Valve Replacement Device - Product Description
Table 30: Cephea Valve Technologies, Inc. - Ongoing Clinical Trials Overview
Table 31: Mitral Valve Replacement Device - Cephea Mitral Valve and Transseptal Delivery System FIH
Table 32: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Mitral Valve - Product Status
Table 34: Mitral Valve - Product Description
Table 35: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status
Table 37: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description
Table 38: Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Direct Flow Medical Transcatheter Mitral Valve - Product Status
Table 40: Direct Flow Medical Transcatheter Mitral Valve - Product Description
Table 41: Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Sutra TMVR System - Product Status
Table 43: Sutra TMVR System - Product Description
Table 44: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 45: CardiAQ Mitral Valve - Product Status
Table 46: CardiAQ Mitral Valve - Product Description
Table 47: EVOQUE Mitral Valve Replacement Device - Product Status
Table 48: EVOQUE Mitral Valve Replacement Device - Product Description
Table 49: FORTIS Mitral Transcatheter Heart Valve - Product Status
Table 50: FORTIS Mitral Transcatheter Heart Valve - Product Description
Table 51: PASCAL Transcatheter Mitral Valve Repair System - Product Status
Table 52: PASCAL Transcatheter Mitral Valve Repair System - Product Description
Table 53: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Status
Table 54: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Description
Table 55: SAPIEN M3 - Product Status
Table 56: SAPIEN M3 - Product Description
Table 57: Second Generation Transapical Transcatheter Mitral Valve - Product Status
Table 58: Second Generation Transapical Transcatheter Mitral Valve - Product Description
Table 59: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 60: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 61: CardiAQ Mitral Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 62: Sapien 3 Heart Valve - Mitral Annular Calcification - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study
Table 63: Sapien 3 Heart Valve - Mitral Annular Calcification - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with Novaflex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery
Table 64: PASCAL Transcatheter Mitral Valve Repair System - CE Mark Study of PASCAL Transcatheter Mitral Valve Repair System

LIST OF FIGURES

Figure 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
Figure 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials

COMPANIES MENTIONED

4C Medical Technologies Inc
Annulon
CardioMech AS
Cardiovalve Ltd
Cephea Valve Technologies, Inc.
Colibri Heart Valve LLC
Daidalos Solutions BV
Dura LLC
Edwards Lifesciences Corp
Emory University
Foldax Inc
HighLife SAS
LivaNova PLC
Medtronic plc
Micro Interventional Devices, Inc.
MitrAssist Ltd.
MValve Technologies Ltd.
NaviGate Cardiac Structures, Inc.
Neovasc Inc
Polares Medical SA
Sino Medical Sciences Technology Inc
Trinity College Dublin
University College London
Venus MedTech


More Publications